Age-related macular degeneration
- PMID: 36996856
- DOI: 10.1016/S0140-6736(22)02609-5
Age-related macular degeneration
Abstract
Age-related macular degeneration is an increasingly important public health issue due to ageing populations and increased longevity. Age-related macular degeneration affects individuals older than 55 years and threatens high-acuity central vision required for important tasks such as reading, driving, and recognising faces. Advances in retinal imaging have identified biomarkers of progression to late age-related macular degeneration. New treatments for neovascular age-related macular degeneration offer potentially longer-lasting effects, and progress is being made towards a treatment for atrophic late age-related macular degeneration. An effective intervention to slow progression in the earlier stages of disease, or to prevent late age-related macular degeneration development remains elusive, and our understanding of underlying mechanistic pathways continues to evolve.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests RHG is a member of the advisory board of Bayer, Novartis, Apellis Pharmaceuticals, and Roche–Genentech; and reports honoraria from Apellis Pharmaceuticals, Bayer, and Novartis; consulting fees from Roche–Genentech; and receipt of loaned equipment from Zeiss. TGC reports being a director of the charitable NQ Eye Foundation and Kumu; payment for lectures from Medical Indemnity Protection Society; and salary support from Bayer through an unrestricted educational grant paid to the Centre for Eye Research Australia.
Similar articles
-
Age-Related Macular Degeneration: Pathophysiology, Management, and Future Perspectives.Ophthalmologica. 2021;244(6):495-511. doi: 10.1159/000517520. Epub 2021 Jun 15. Ophthalmologica. 2021. PMID: 34130290 Review.
-
Sub-retinal neovascular membrane in exudative macular degeneration.Clin Exp Optom. 2003 Jan;86(1):51-6. doi: 10.1111/j.1444-0938.2003.tb03058.x. Clin Exp Optom. 2003. PMID: 12568652
-
[Age-related macular degeneration].Rev Prat. 1996 Sep 15;46(14):1722-9. Rev Prat. 1996. PMID: 8949279 Review. French.
-
[Age-related macular degeneration diagnosis].Rev Prat. 2017 Jan;67(1):92-95. Rev Prat. 2017. PMID: 30512446 French.
-
Association of Visit Adherence and Visual Acuity in Patients With Neovascular Age-Related Macular Degeneration: Secondary Analysis of the Comparison of Age-Related Macular Degeneration Treatment Trial.JAMA Ophthalmol. 2020 Mar 1;138(3):237-242. doi: 10.1001/jamaophthalmol.2019.4577. JAMA Ophthalmol. 2020. PMID: 32027349 Free PMC article. Clinical Trial.
Cited by
-
A Two-Decade Bibliometric Analysis of Laser in Ophthalmology: From Past to Present.Clin Ophthalmol. 2024 May 13;18:1313-1328. doi: 10.2147/OPTH.S458840. eCollection 2024. Clin Ophthalmol. 2024. PMID: 38765459 Free PMC article. Review.
-
Effects and potential mechanisms of exercise and physical activity on eye health and ocular diseases.Front Med (Lausanne). 2024 Mar 22;11:1353624. doi: 10.3389/fmed.2024.1353624. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38585147 Free PMC article. Review.
-
A Novel Electromagnetic Driving System for 5-DOF Manipulation in Intraocular Microsurgery.Cyborg Bionic Syst. 2024 Mar 23;5:0083. doi: 10.34133/cbsystems.0083. eCollection 2024. Cyborg Bionic Syst. 2024. PMID: 38533379 Free PMC article.
-
Clinical Outcomes Following a Switch of Therapy to Faricimab in Patients Affected by Neovascular Age-Related Macular Degeneration.J Clin Med. 2025 Jan 10;14(2):423. doi: 10.3390/jcm14020423. J Clin Med. 2025. PMID: 39860429 Free PMC article.
-
AMD-SD: An Optical Coherence Tomography Image Dataset for wet AMD Lesions Segmentation.Sci Data. 2024 Sep 18;11(1):1014. doi: 10.1038/s41597-024-03844-6. Sci Data. 2024. PMID: 39294152 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
